Nonrandomized Controlled Trial: Clinical impact of intraoperative margin assessment in breast-conserving surgery with a novel Pegulicianine Fluorescence–guided system.

Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence–Guided System: A Nonrandomized Controlled Trial – JAMA Surgery

Commentary on Twitter

New intraoperative margin detection technology is safe and reduces reexcision rates in patients undergoing breast conserving surgery! (include infographic) #bcsm https://t.co/NqUOhGJBo4

— JAMA Surgery (@JAMASurgery) May 11, 2022